| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-10 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0004 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.002 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |